Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Reviva Pharmaceuticals Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | N/A | -$0.25 | N/A | N/A | $0 |
| 08/14/2024 | Q2 2024 | N/A | -$0.26 | N/A | N/A | $0 |
| 05/14/2024 | Q1 2024 | N/A | -$0.25 | N/A | N/A | $0 |
| 04/15/2024 | Q4 2023 | N/A | $0.00 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.44 | N/A | N/A | $0 |
| 08/14/2023 | Q2 2023 | N/A | -$0.55 | N/A | N/A | $0 |
| 05/15/2023 | Q1 2023 | N/A | -$0.30 | N/A | N/A | $0 |
| 03/30/2023 | Q4 2022 | N/A | -$0.42 | N/A | N/A | $0 |
| 11/14/2022 | Q3 2022 | N/A | -$0.18 | N/A | N/A | $0 |
| 08/15/2022 | Q2 2022 | N/A | -$0.29 | N/A | N/A | $0 |
| 05/16/2022 | Q1 2022 | N/A | -$0.40 | N/A | N/A | $0 |
| 03/15/2022 | Q4 2021 | N/A | -$0.29 | N/A | N/A | $0 |
| 11/15/2021 | Q3 2021 | N/A | -$0.12 | N/A | N/A | $0 |
| 08/16/2021 | Q2 2021 | N/A | -$0.12 | N/A | N/A | $0 |
| 05/17/2021 | Q1 2021 | N/A | -$0.10 | N/A | N/A | $0 |
| 03/22/2021 | Q4 2020 | N/A | -$0.17 | N/A | N/A | $0 |
| 10/14/2020 | Q3 2020 | N/A | -$0.24 | N/A | N/A | $0 |
| 07/07/2020 | Q2 2020 | N/A | -$0.31 | N/A | N/A | $0 |
| 05/01/2020 | Q1 2020 | N/A | -$0.27 | N/A | N/A | $0 |
| 01/10/2020 | Q4 2019 | N/A | $0.05 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Reviva Pharmaceuticals Holdings, Inc. Earnings: FAQ's
Reviva Pharmaceuticals Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based offlast year's report dates.
The conference call for Reviva Pharmaceuticals Holdings, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Reviva Pharmaceuticals Holdings, Inc.'s latest earnings report can be read online.
Reviva Pharmaceuticals Holdings, Inc. (:RVPHW) has a recorded net income of $-39,260,837,000,000.Reviva Pharmaceuticals Holdings, Inc. has generated $-1.65 earnings per share over the last four quarters.
Reviva Pharmaceuticals Holdings, Inc. (:RVPHW) has a price-to-earnings ratio of -0.6 and price/earnings-to-growth ratio is -0.03.